Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v13-EN Version v2-EN
Language English English
Date Updated 2022-08-17 2022-06-15
Drug Identification Number 02499711 02499711
Brand name CEFTRIAXONE INJECTION, USP CEFTRIAXONE INJECTION, USP
Common or Proper name CEFTRIAXONE INJECTION, USP CEFTRIAXONE INJECTION, USP
Company Name BAXTER CORPORATION BAXTER CORPORATION
Ingredients CEFTRIAXONE CEFTRIAXONE
Strength(s) 1000MG 1000MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 50mL 50mL
ATC code J01DD J01DD
ATC description OTHER BETA-LACTAM ANTIBACTERIALS OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2022-06-17 2022-06-17
Actual start date 2022-06-17 2022-06-17
Estimated end date 2022-08-16 2022-06-30
Actual end date 2022-08-16
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments